Skip to main content
S&P 5007,706.03-0.75%DOW51,511.59-0.68%NASDAQ26,936.04-1.13%BTC$84,260.00-2.56%ETH$2,680.98-2.93%GOLD$4,329.80+0.26%OIL$91.55-0.66%
Smart Investors Daily
AD

NASDAQ · ADUS

Addus HomeCare Corporation

Healthcare · Medical - Care Facilities

$114.24

Up+$0.69 (+0.60%)

Updated Sep 24, 2026, 1:35 AM

SID Score

5.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.91B
P/E ratio
19.91
Dividend yield
0.00%
52-week range
$87.95 – $124.44
Volume
154.48K
Avg. volume
212.6K

Price performance

ADUS price history

1M range · 0 trading sessions · Daily adjusted prices

ADUS does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest ADUS news

The latest Smart Investors Daily articles mentioning ADUS.

Stock researchCompany · Overview

ADUS research

Overview

Company profile and research snapshot.

Company profile

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$131.00
Implied upside
—
Analysts
—
ADUS recent ratings
DateFirmRatingTarget
Sep 14, 2026B of A SecuritiesNeutral—
Aug 5, 2026RBC CapitalOutperform—
Jul 9, 2026BarclaysUnderweight—
May 18, 2026CitizensMarket Outperform—
May 15, 2026BarclaysUnderweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 16, 2026

Addus HomeCare (ADUS) Heads To Jefferies, Is It Still 13% Undervalued?

Addus HomeCare (ADUS) heads into its 2026 Jefferies Healthcare Services and Technology Conference appearance with fresh attention on its AccentCare personal care acquisition and the stock’s recent sector driven move. After a strong run that produced a 23.45% 90 day share price return and lifted year to date share price gains to 8.73%, Addus HomeCare has seen momentum cool slightly in the last week as investors weigh the AccentCare deal, evolving Medicaid headlines, and the stock’s longer term...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By